Vineet Laboratories Limited

Total Valuation

Vineet Laboratories Limited carries a market capitalization of 306.50M, placing it among publicly traded companies globally. Its enterprise value stands at 383.24M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Valuation Ratios

Enterprise Valuation

Financial Position

Vineet Laboratories Limited maintains a current ratio of 2.77, meaning it holds 2.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 860.11, indicating elevated leverage, while an interest coverage ratio of -1.63 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Stock Price Statistics

Vineet Laboratories Limited's stock has gained approximately 2.69773% over the past 52 weeks. The 50-day moving average sits at 35.33, while the 200-day moving average is 36.10.

Income Statement

Over the trailing twelve months, Vineet Laboratories Limited generated 545.86M in revenue and converted that into -101.39M in net income, yielding earnings per share of -9.72. EBITDA reached -75.95M, while operating income came in at -75.95M.

Margins

Vineet Laboratories Limited operates with a gross margin of 11.23, reflecting its pricing power and cost economics. The operating margin of -13.91 and net profit margin of -18.57 provide insight into operational efficiency.

Scores

Vineet Laboratories Limited posts an Altman Z-Score of 0.58, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.